UA113416C2 - STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENT - Google Patents
STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENTInfo
- Publication number
- UA113416C2 UA113416C2 UAA201405946A UAA201405946A UA113416C2 UA 113416 C2 UA113416 C2 UA 113416C2 UA A201405946 A UAA201405946 A UA A201405946A UA A201405946 A UAA201405946 A UA A201405946A UA 113416 C2 UA113416 C2 UA 113416C2
- Authority
- UA
- Ukraine
- Prior art keywords
- hyaluronic acid
- therapeutic activity
- solution based
- decametoxin
- pharmaceutic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід стосується стабілізованого розчину на основі декаметоксину та гіалуронової кислоти з терапевтичною активністю щодо пригнічення спайкового процесу з одночасною протизапальною, антисептичною, регенеруючою та зволожуючою дією, що додатково містить стабілізатор, який є фармацевтично прийнятною сіллю, яка здатна до розчинення у воді та дисоціації у водних розчинах на катіони металів та аніони кислотних залишків, або сумішшю таких солей, способу його отримання та фармацевтичної композиції на його основі.The invention relates to a stabilized solution based on decamethoxin and hyaluronic acid with therapeutic activity for the inhibition of adhesions with simultaneous anti-inflammatory, antiseptic, regenerating and moisturizing action, additionally containing a stabilizer, which is a pharmaceutically acceptable salt, to cations of metals and anions of acid residues, or a mixture of such salts, method of production thereof and pharmaceutical compositions based thereon.
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201405946A UA113416C2 (en) | 2014-05-30 | 2014-05-30 | STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENT |
| PL420378A PL420378A1 (en) | 2014-05-30 | 2015-06-02 | Stabilized solution on the basis of active substances, method for obtaining stabilized solution on the basis of active substances, pharmaceutical composition on the basis of stabilized solution of active substances (two variants) |
| RU2016148820A RU2016148820A (en) | 2014-05-30 | 2015-06-02 | STABILIZED SOLUTION BASED ON ACTIVE SUBSTANCES, METHOD FOR PRODUCING A STABILIZED SOLUTION OF ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION BASED ON A STABILIZED SOLUTION OF ACTIVE SUBSTANCES (OPTIONS) |
| CN201580022510.1A CN106794140A (en) | 2014-05-30 | 2015-06-02 | Pharmaceutical composition based on active material stablizing solution |
| PCT/UA2015/000047 WO2015183230A1 (en) | 2014-05-30 | 2015-06-02 | Composition based on a stabilized solution of active ingredients |
| ROA201600960A RO131947A2 (en) | 2014-05-30 | 2015-06-02 | Stabilized solution based on active ingredients and method for preparing the stabilized solution of active ingredients |
| MX2016015660A MX2016015660A (en) | 2014-05-30 | 2015-06-02 | Composition based on a stabilized solution of active ingredients. |
| BR112016028176A BR112016028176A2 (en) | 2014-05-30 | 2015-06-02 | stabilized solution based on two active substances, method for preparing the stabilized solution and pharmaceutical compositions based on the stabilized active substance solution |
| EA201691825A EA033306B1 (en) | 2014-05-30 | 2015-06-02 | Stabilized solution based on active ingredients, method for preparing a stabilized solution of active ingredients, pharmaceutical composition based on a stabilized solution of active ingredients (two variants) |
| EP15799012.8A EP3153156A4 (en) | 2014-05-30 | 2015-06-02 | Composition based on a stabilized solution of active ingredients |
| CONC2016/0004668A CO2016004668A2 (en) | 2014-05-30 | 2016-11-28 | Composition based on a stabilized solution of active ingredients |
| CL2016003063A CL2016003063A1 (en) | 2014-05-30 | 2016-11-29 | Composition based on a stabilized solution of active ingredients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201405946A UA113416C2 (en) | 2014-05-30 | 2014-05-30 | STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA113416C2 true UA113416C2 (en) | 2017-01-25 |
Family
ID=58049652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201405946A UA113416C2 (en) | 2014-05-30 | 2014-05-30 | STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENT |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA113416C2 (en) |
-
2014
- 2014-05-30 UA UAA201405946A patent/UA113416C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022007915A (en) | Benzopyrazole compounds and analogues thereof. | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| PH12017500914A1 (en) | Bile acid analogs as fxr/tgr5 agonists and methods of use thereof | |
| MX2017005935A (en) | Bile acid analogs an fxr/tgr5 agonists and methods of use thereof. | |
| PH12018500065A1 (en) | Oxysterols and methods of use thereof | |
| TW201612158A (en) | Amide derivatives and salts thereof, preparation process and pharmaceutical use thereof | |
| PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
| MX2017004618A (en) | Heparan sulfate biosynthesis inhibitors for the treatment of diseases. | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| MX2016011105A (en) | Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders. | |
| MX370141B (en) | Prodrugs comprising an glp-1/glucagon dual agonist linker hyaluronic acid conjugate. | |
| NZ746825A (en) | Oxysterols and methods of use thereof | |
| WO2015187542A8 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| PH12017500913A1 (en) | Substituted bridged urea analogs as sirtuin modulators | |
| MX2016012318A (en) | Amide compound. | |
| MX2017013099A (en) | Methods for the treatment of inflammatory disorders. | |
| EA035519B9 (en) | 1,3,4-thiadiazole compounds and their use in treating cancer | |
| PH12016502568B1 (en) | Novel heterocyclic compound | |
| PL420378A1 (en) | Stabilized solution on the basis of active substances, method for obtaining stabilized solution on the basis of active substances, pharmaceutical composition on the basis of stabilized solution of active substances (two variants) | |
| MX2018002177A (en) | Novel catechol derivative and pharmaceutical composition comprising same. | |
| MY198753A (en) | Treatment of androgen deprivation therapy associated symptoms | |
| UA113416C2 (en) | STABILIZED SOLUTION BASED ON DECAMETOXIN AND Hyaluronic Acid, THAT HAS THERAPEUTIC ACTIVITY, METHOD OF ITS ADMINISTRATION AND PHARMACEUTIC TREATMENT | |
| MX2017013103A (en) | Methods for the treatment of cardiovascular disorders. | |
| TH167687B (en) | Medicine to prevent or treat constipation |